News
NewsPharma Pulse
Academy
Publications
Partner Perspectives
More
Webcasts
Resources
Conferences
Conference CoverageConference Listing
Events
Videos
VideosPeer Exchange
Podcasts
Editorial PodcastsSponsored Podcasts

Subscribe

  • News
  • Academy
  • Publications
  • Partner Perspectives
  • Webcasts
  • Resources
  • Conferences
  • Events
  • Videos
  • Podcasts
  • Subscribe
  • Brand & Product Security
    • Legal & Regulatory
    • Trade & Brand Protection
    • Traceability
  • Business and Finance
  • Cold Chain
    • Containers & Shippers
    • Software
    • Devices
  • Commercial Channels
  • Data & Technology
    • Real World Data
    • Digitalization
    • Artificial Intelligence
  • Logistics & Transportation
    • Manufacturing & Packaging
    • 3PL
    • Supply Chain
  • Market Access
    • Pricing
    • Commercialization
    • Trade & Channel
  • Opinion
  • Patient Support
    • Patient Assistance Programs
    • HUB Services
    • Adherence
Spotlight -
Digital Editions|
Security|
Asembia AXS25 Summit
Advertisement

Nancy Dreyer, MPH, PhD, Quintiles Outcome

Advertisement

Articles by Nancy Dreyer, MPH, PhD, Quintiles Outcome

Ensuring the quality of comparative effectiveness research

ByNancy Dreyer, MPH, PhD, Quintiles Outcome
August 28th 2012

As payers seek higher-quality data from real-world treatment settings, the importance of reliable measures becomes critical

Advertisement

Latest Updated Articles

  • Ensuring the quality of comparative effectiveness research
    Ensuring the quality of comparative effectiveness research

    Published: August 28th 2012 | Updated:



Advertisement
Advertisement

Trending on Pharmaceutical Commerce

1

BioNTech Launches Public Exchange Offer for CureVac in $1.25B All-Stock Deal

2

Pharma Pulse: Alkermes Acquires Avadel in $2.1B Deal, BioNTech Moves to Buy CureVac, and MedTech Industry Embraces Digital-First Models

3

Pharma Pulse: MJH Life Sciences Expands into Health Systems, Novo Nordisk Board Shakeup Moves Markets, and Mark Cuban Grows Cost Plus Drugs Network

4

Mark Cuban Confirms Cost Plus Drugs Partnership

5

The Unsung Allies Helping Patients Navigate Specialty Drug Access

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us